CC BY 4.0 · The Arab Journal of Interventional Radiology 2023; 07(S 01): S1-S41
DOI: 10.1055/s-0043-1763312
Category: Vascular Interventions

The Effectiveness of Endovascular Procedures for the Treatment of Vascular Access with CAS

Georgios Nistikoulis
1   Interventional Radiology, Patras University Hospital, Patras, Greece
,
Panagiotis Kitrou
1   Interventional Radiology, Patras University Hospital, Patras, Greece
,
Michail Theofanis
1   Interventional Radiology, Patras University Hospital, Patras, Greece
,
Fotios Anagnostopoulos
1   Interventional Radiology, Patras University Hospital, Patras, Greece
,
Christos Papageorgiou
1   Interventional Radiology, Patras University Hospital, Patras, Greece
,
Evangelia Christodoulou
1   Interventional Radiology, Patras University Hospital, Patras, Greece
,
Nikolaos Giannikas
1   Interventional Radiology, Patras University Hospital, Patras, Greece
,
Platon Dimopoulos
1   Interventional Radiology, Patras University Hospital, Patras, Greece
,
Konstantinos Katsanos
1   Interventional Radiology, Patras University Hospital, Patras, Greece
,
Dimitrios Karnabatidis
1   Interventional Radiology, Patras University Hospital, Patras, Greece
› Author Affiliations
 

Introduction: This is a single-center retrospective analysis to evaluate the effectiveness of endovascular procedures for the treatment of dysfunctional vascular access with cephalic arch stenosis (CAS).

Method(s): In 41 months, 56 patients underwent 90 procedures for the treatment of their dysfunctional vascular access with CAS. Most frequent comorbidities were hypertension and smoking. Patients were treated with High-Pressure Balloon (HPB) angioplasty only, Paclitaxel-Coated Balloon (PCB) angioplasty or Covered Stent (CS) insertion. Primary outcome measures were target lesion primary patency (TLPP) at 6 months assessed with Kaplan–Meier survival analysis and procedural success.

Result(s): Procedural success: 100%. Mean follow-up: 643 days. HPB angioplasty: 50 cases (55.5%), PCBs: 14 cases (15.6%), and CS: 26 cases (28.9%). TLPP at 6 months: 54% for HPB, for PCB and 80.77% for CS (p < 0.0001), and 31.9, 64.3, and 76.9% at 12 months, respectively.

Conclusion(s): In this retrospective analysis, PCBs and CSs had similar results for the treatment of CAS and significantly better than HPB angioplasty.



Publication History

Article published online:
09 February 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India